Superstring Capital Management LP

Superstring Capital Management LP reported 35 holdings worth US$200M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Superstring Capital Management LP reported 35 holdings worth US$200M as of Sep 30, 2026. Largest: Cogent Biosciences, Inc., Axsome Therapeutics, Inc. and Trevi Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
35
Value as reported
US$200M

The filing in full

CompanySharesValue as reported% of portfolio
Cogent Biosciences, Inc.597KUS$19.1M9.6%
Axsome Therapeutics, Inc.102KUS$18.9M9.5%
Trevi Therapeutics, Inc.985KUS$14.1M7.1%
Genmab A/S366KUS$13M6.5%
Climb Bio, Inc.918KUS$10.5M5.3%
Zai Lab Ltd.363KUS$9.55M4.8%
Adlai Nortye Group Ltd.588KUS$9.41M4.7%
Revolution Medicines, Inc.41,784US$8.58M4.3%
Celldex Therapeutics, Inc.242KUS$7.86M3.9%
Immunovant, Inc.222KUS$7.5M3.8%
United Therapeutics Corporation13,321US$7.22M3.6%
Legend Biotech Corp.357KUS$7.11M3.6%
Definium Therapeutics, Inc.177KUS$6.72M3.4%
Roivant Sciences Ltd.179KUS$6.54M3.3%
Vir Biotechnology, Inc.579KUS$6.47M3.2%
Ionis Pharmaceuticals, Inc.132KUS$5.91M3.0%
Savara, Inc.1.02MUS$5.25M2.6%
Sagimet Biosciences Inc. - Series A423KUS$4.18M2.1%
Abivax SA30,020US$2.97M1.5%
Ginkgo Bioworks Holdings, Inc.223KUS$2.86M1.4%
Spyre Therapeutics, Inc.30,022US$2.67M1.3%
Bright Minds Biosciences Inc.48,045US$2.39M1.2%
Taysha Gene Therapies, Inc.413KUS$2.01M1.0%
Latigo Biotherapeutics, Inc.88,178US$1.47M0.74%
Oruka Therapeutics, Inc.15,446US$1.29M0.64%
MapLight Therapeutics, Inc.118KUS$1.21M0.60%
Madrigal Pharmaceuticals, Inc.2,099US$1.06M0.53%
Cabaletta Bio, Inc.517KUS$993K0.50%
Xenon Pharmaceuticals Inc.26,496US$985K0.49%
Tonix Pharmaceuticals Holding Corp.74,688US$727K0.36%
Boundless Bio, Inc.206KUS$518K0.26%
GRAIL, Inc.3,238US$454K0.23%
Biomea Fusion, Inc.226KUS$44,5650.02%
Aclaris Therapeutics, Inc.0US$00.00%
BeOne Medicines Ltd. Class A0US$00.00%
Cybin, Inc.0US$00.00%
Sensei Biotherapeutics, Inc.0US$00.00%
ORIC Pharmaceuticals, Inc.0US$00.00%
Protara Therapeutics, Inc.0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%
Vaxcyte, Inc.0US$00.00%
VYNE Therapeutics Inc.0US$00.00%

Source

Download original · View original at SEC

Related